drugset / Trial / NCT01445860

Drug-Drug Interaction Study Of Effect Of PF-03882845 On Simvastatin Pharmacokinetics

NCT01445860

Phase 1 Completed 14 enrolled Pfizer
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to estimate the effect of multiple oral doses of PF-03882845 on the pharmacokinetics of simvastatin and simvastatin acid in healthy, adult subjects.

Timeline

Start
2011-08
Primary completion
2011-09
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-03882845 Small molecule 30 mg
Subject Simvastatin Small molecule 20 mg

Indications

No indication recorded.